David Young

Dr. Young has over 30 years of pharmaceutical research, drug development, and corporate experience. He is currently a founder, CEO and board member of Processa Pharmaceuticals. He has had multiple successful exits, including Questcor Pharmaceuticals and GloboMax. Dr. Young has met more than 100 times with the FDA on more than 50 drug products, and was previously a Tenured Associate Professor at the School of Pharmacy, University of Maryland.

Dr. Young received his B.S. in Physiology from the University of California at Berkeley, his M.S. in Medical Physics from the University of Wisconsin at Madison, and his Pharm.D. - Ph.D. with emphasis in Pharmacokinetics and Pharmaceutical Sciences from the University of Southern California.